In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
- Journal
- SHILAP Revista de lepidopterología
In The Last Decade
doi.org/10.1002/exp.20220161 →Countries where authors are citing In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
This map shows the geographic impact of In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms more than expected).
Fields of papers citing In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
This network shows the impact of In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms.
About In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
This paper, published in 2023, received 112 indexed citations . Written by Jingwen Ma, Na Li, Zhe Liu, Yulong Han and Yun Zeng covering the research area of Molecular Biology, Materials Chemistry and Biomedical Engineering. It is primarily cited by scholars working on Biomedical Engineering (97 citations), Materials Chemistry (53 citations) and Molecular Biology (28 citations). Published in SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1002/exp.20220161.